Comparative analysis of detecting monocytic cells and their aberrancy

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 4, 2011, Pages 336-340

  Dunphy, Cherie H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

aberrancy; CD123; CD14; CD163; CD2; CD56; CD68; flow cytometry; immunohistochemistry; monocytic cells

Indexed keywords

CD123 ANTIBODY; CD14 ANTIBODY; CD163 ANTIBODY; CD2 ANTIBODY; CD3 ANTIBODY; CD33 ANTIBODY; CD68 ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACUTE MONOCYTIC LEUKEMIA; ANTIGEN DETECTION; ARTICLE; BONE MARROW BIOPSY; CHRONIC MYELOMONOCYTIC LEUKEMIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MONOCYTE MACROPHAGE PRECURSOR CELL; PRIORITY JOURNAL;

ANTIGENS, CD; BIOPSY; BONE MARROW CELLS; CELL SEPARATION; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID; MONOCYTES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 79959317537     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3182052805     Document Type: Article

References (9)

1. Dunphy CH, Orton SO, Mantell JJ. Relative contributions of enzyme cytochemistry and flow cytometric immunophenotyping to the evaluation of acute myeloid leukemias with a monocytic component and of flow cytometric immunophenotyping to the evaluation of absolute monocytoses. Am J Clin Pathol. 2004;122:865-874. (Pubitemid 39577354)
2. Xu Y, McKenna RW, Karandikar NJ, et al. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol. 2005;124: 799-806. (Pubitemid 41532515)
3. Bennett JM, Catovsky D, Daniel M-T, et al. Proposals for the classification of the acute leukemias: French-American-British (FAB) Co-operative Group. Br J Haematol. 1976;33:451-453.
4. Brunning RD, Matutes E, Harris NL, et al. Acute myeloid leukemia. In: Jaffe ES, Harris NL, Stein H, et al. eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:74-107. World Health Organization Classification of Tumours.
5. Dunphy CH, Tang W. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases. Arch Pathol Lab Med. 2007;131: 748-754. (Pubitemid 46726136)
6. Nomura Y, Takeuchi M, Yoshida S, et al. Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis. Pathol Int. 2009;59:631-635.
7. Qubaja M, Marmey B, Le Tourneau A, et al. The detection of CD14 and CD16 in paraffin-embedded bone marrow biopsies is useful for the diagnosis of chronic myelomonocytic leukemia. Virchows Arch. 2009;454:411-419.
8. Orazi A, Chiu R, O'Malley DP, et al. Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Mod Pathol. 2006;19:1536-1545. (Pubitemid 44789921)
9. Du X, Ho M, Pastan I. New immunotoxins targeting CD123: a stem cell antigen on acute myeloid leukemia cells. J Immunother. 2007; 30:607-613. (Pubitemid 47229695)